Skip to content
April 18, 2024

Equity.Guru

Investment information for the new generation

Search

Scribes

In my inaugural Agriculture round up piece, I highlighted my broader macro article on this sector. I gave my reasons for being bullish. Before we ended 2020, Canada’s Food…
The biggest spate of news actually happened last Friday and it’s China again. Now all cryptocurrency related transactions are effectively banned in China. The effects were immediate:   Coinbase…
A comparable company analysis is a method used to appraise the value of a concern using the metrics of other businesses of similar scope in the same industry. Comparable…
In this episode, Jody Vance catches up with Equity Guru’s founder and CEO Chris Parry to talk about EG’s latest changes and updates to content and team members. Tune…
30 September 2021
Bonds 101
I am not saying I want the attention of a cult, but I am saying that it would be nice to have that sense of community.   (Don’t concern…
In this episode, Jody Vance catches up with Equity Guru’s founder and CEO Chris Parry to talk about the company’s latest updates and New Extreme Wrestling. Tune In! …
In this episode, Jody Vance catches up with Equity Guru’s founder and CEO Chris Parry to talk about the company’s latest updates and New Extreme Wrestling. Tune In! …
NuCana PLC (NCNA.Q) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to Acerlarin® (NUC-1031), which is currently being evaluated in a Phase…
I have been keeping tabs on Ethereum and other cryptocurrencies as they attempt to climb back over an important resistance zone. This needs to happen for me to shift…
Drug science is all about timing. You can either take a preexisting molecule, which has benefits for alternative indications rather than what it’s originally on shelves for, and you…